Canadian Cancer Trials Group

Canadian Cancer Trials Group Special Bulletin

18 May 2017

Group Administrators Office

ESMO clinical benefits scale

It has been 2 years since the publication of the ESMO clinical benefits scale. Please consider talking a short survey to assist in determining how the scale is being used in different countries. To garner information from Canadian oncology community the survey deadline has been extended.

The access to the short survey is

You are receiving this Bulletin because of your involvement with the Canadian Cancer Trials Group. If you no longer wish to receive Canadian Cancer Trials Group Bulletins, please send an unsubscribe request by clicking here.

If you have any questions, comments or suggestions, please contact